Why is Shanghai General Healthy Information & Technology Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.12% and Operating profit at -77.30% over the last 5 years
2
Negative results in Mar 25
- INTEREST(HY) At CNY 1.78 MM has Grown at 257.1%
- PRE-TAX PROFIT(Q) At CNY 2.99 MM has Fallen at -57.52%
- DEBT-EQUITY RATIO (HY) Highest at 9.53 %
3
With ROE of 0.37%, it has a expensive valuation with a 2.53 Price to Book Value
- Over the past year, while the stock has generated a return of -21.83%, its profits have fallen by -77.5%
4
Below par performance in long term as well as near term
- Along with generating -21.83% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai General Healthy Information & Technology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai General Healthy Information & Technology Co., Ltd.
-21.83%
-0.70
36.32%
China Shanghai Composite
12.36%
0.86
14.45%
Quality key factors
Factor
Value
Sales Growth (5y)
1.12%
EBIT Growth (5y)
-77.30%
EBIT to Interest (avg)
77.56
Debt to EBITDA (avg)
0.47
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.27
Tax Ratio
13.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.44%
ROE (avg)
8.77%
Valuation Key Factors 
Factor
Value
P/E Ratio
676
Industry P/E
Price to Book Value
2.53
EV to EBIT
2782.96
EV to EBITDA
105.07
EV to Capital Employed
2.45
EV to Sales
8.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.03%
ROE (Latest)
0.37%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
18What is working for the Company
NET SALES(HY)
At CNY 197.48 MM has Grown at 96.84%
NET PROFIT(HY)
At CNY 6.74 MM has Grown at 184.08%
OPERATING CASH FLOW(Y)
Highest at CNY 53.57 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.28%
-16What is not working for the Company
INTEREST(HY)
At CNY 1.78 MM has Grown at 257.1%
PRE-TAX PROFIT(Q)
At CNY 2.99 MM has Fallen at -57.52%
DEBT-EQUITY RATIO
(HY)
Highest at 9.53 %
NET PROFIT(Q)
At CNY 3.43 MM has Fallen at -43.26%
RAW MATERIAL COST(Y)
Grown by 43.92% (YoY
Here's what is working for Shanghai General Healthy Information & Technology Co., Ltd.
Net Sales
At CNY 197.48 MM has Grown at 96.84%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (CNY MM)
Operating Cash Flow
Highest at CNY 53.57 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Highest at 3.28%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Shanghai General Healthy Information & Technology Co., Ltd.
Interest
At CNY 1.78 MM has Grown at 257.1%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Pre-Tax Profit
At CNY 2.99 MM has Fallen at -57.52%
over average net sales of the previous four periods of CNY 7.05 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 3.43 MM has Fallen at -43.26%
over average net sales of the previous four periods of CNY 6.04 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at 9.53 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 43.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






